486 related articles for article (PubMed ID: 22292524)
1. Alternate strategies to obtain mass balance without the use of radiolabeled compounds: application of quantitative fluorine (19F) nuclear magnetic resonance (NMR) spectroscopy in metabolism studies.
Mutlib A; Espina R; Atherton J; Wang J; Talaat R; Scatina J; Chandrasekaran A
Chem Res Toxicol; 2012 Mar; 25(3):572-83. PubMed ID: 22292524
[TBL] [Abstract][Full Text] [Related]
2. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
[TBL] [Abstract][Full Text] [Related]
3. Comparison between Radioanalysis and
Hu H; Katyayan KK; Czeskis BA; Perkins EJ; Kulanthaivel P
Drug Metab Dispos; 2017 Apr; 45(4):399-408. PubMed ID: 28188298
[TBL] [Abstract][Full Text] [Related]
4. Utilizing 19F NMR to investigate drug disposition early in drug discovery.
Hu H; Huang N; Yi P; Hui YH; Dally RD; Ehlhardt WJ; Kulanthaivel P
Xenobiotica; 2015; 45(12):1081-91. PubMed ID: 25946562
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance spectroscopy for measuring the biodistribution and in situ in vivo pharmacokinetics of fluorinated compounds: validation using an investigation of liver and heart disposition of tecastemizole.
Schneider E; Bolo NR; Frederick B; Wilkinson S; Hirashima F; Nassar L; Lyoo IK; Koch P; Jones S; Hwang J; Sung Y; Villafuerte RA; Maier G; Hsu R; Hashoian R; Renshaw PF
J Clin Pharm Ther; 2006 Jun; 31(3):261-73. PubMed ID: 16789992
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs.
Martino R; Gilard V; Desmoulin F; Malet-Martino M
J Pharm Biomed Anal; 2005 Aug; 38(5):871-91. PubMed ID: 16087049
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.
Espina R; Yu L; Wang J; Tong Z; Vashishtha S; Talaat R; Scatina J; Mutlib A
Chem Res Toxicol; 2009 Feb; 22(2):299-310. PubMed ID: 18980340
[TBL] [Abstract][Full Text] [Related]
8. Application of quantitative NMR in pharmacological evaluation of biologically generated metabolites: implications in drug discovery.
Mutlib A; Espina R; Vishwanathan K; Babalola K; Chen Z; Dehnhardt C; Venkatesan A; Mansour T; Chaudhary I; Talaat R; Scatina J
Drug Metab Dispos; 2011 Jan; 39(1):106-16. PubMed ID: 20952552
[TBL] [Abstract][Full Text] [Related]
9. Studies of metabolism and disposition of potent human immunodeficiency virus (HIV) integrase inhibitors using 19F-NMR spectroscopy.
Monteagudo E; Pesci S; Taliani M; Fiore F; Petrocchi A; Nizi E; Rowley M; Laufer R; Summa V
Xenobiotica; 2007 Sep; 37(9):1000-12. PubMed ID: 17896326
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICPMS and HPLC-NMR.
Duckett CJ; Lindon JC; Walker H; Abou-Shakra F; Wilson ID; Nicholson JK
Xenobiotica; 2006 Jan; 36(1):59-77. PubMed ID: 16507513
[TBL] [Abstract][Full Text] [Related]
11. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of nevirapine, a non-nucleoside HIV-1 reverse transcriptase inhibitor, in mice, rats, rabbits, dogs, monkeys, and chimpanzees.
Riska PS; Joseph DP; Dinallo RM; Davidson WC; Keirns JJ; Hattox SE
Drug Metab Dispos; 1999 Dec; 27(12):1434-47. PubMed ID: 10570025
[TBL] [Abstract][Full Text] [Related]
13. Comparison of
James AD; Marvalin C; Luneau A; Meissner A; Camenisch G
Drug Metab Dispos; 2017 Aug; 45(8):900-907. PubMed ID: 28566285
[TBL] [Abstract][Full Text] [Related]
14. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
15. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
16. Use of 19F-nuclear magnetic resonance and gas chromatography-electron capture detection in the quantitative analysis of fluorine-containing metabolites in urine of sevoflurane-anaesthetized patients.
Orhan H; Commandeur JN; Sahin G; Aypar U; Sahin A; Vermeulen NP
Xenobiotica; 2004 Mar; 34(3):301-16. PubMed ID: 15204701
[TBL] [Abstract][Full Text] [Related]
17. In vivo metabolism of [14C]ruboxistaurin in dogs, mice, and rats following oral administration and the structure determination of its metabolites by liquid chromatography/mass spectrometry and NMR spectroscopy.
Barbuch RJ; Campanale K; Hadden CE; Zmijewski M; Yi P; O'Bannon DD; Burkey JL; Kulanthaivel P
Drug Metab Dispos; 2006 Feb; 34(2):213-24. PubMed ID: 16258078
[TBL] [Abstract][Full Text] [Related]
18. Nuclear magnetic resonance (NMR)-based drug metabolite profiling.
Lenz EM
Methods Mol Biol; 2011; 708():299-319. PubMed ID: 21207298
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
